A Survey of the Cases
The survey below employs a few set parameters. First, the survey includes decisions in cases brought under section 10(b) of the Exchange Act and Securities and Exchange Commission (SEC) Rule 10b-5, in which the court addressed statistical significance in assessing either the fraud-on-the-market presumption or loss causation. Second, the survey includes decisions published on WestLaw from January 1, 2023, through February 7, 2025. The results are intended to be comprehensive, but it is possible some decisions were missed.
In total, the survey identified 46 decisions. Of those, 34 decisions referenced the parties’ arguments on whether a stock price movement was statistically significant, but the court did not address the appropriate threshold for significance or whether statistical significance is dispositive of an issue in the case. In each of these decisions, the parties and court expressly or impliedly applied the 95 percent threshold for statistical significance, without party dispute or argument.
Of the remaining 12 decisions, one stated in dicta that a lack of statistical significance necessarily means that price movements were not caused by an alleged misrepresentation or corrective disclosure. See Ark. Teacher Ret. Sys. v. Goldman Sachs Grp., Inc., 77 F. 4th 74, 86 n.5 (2d Cir. 2023) (“If the stock price movement is indistinguishable from random price fluctuations, it cannot be attributed to company-specific information announced on the event date.”). One decision used the term “statistical significance” to describe the absolute size of a stock price change (rather than using the term to correctly refer to a measure using regression), mistakenly concluding that if a stock price drops more than 10 percent in total, the drop is necessarily “statistically significant” and lower absolute drops are not. See Ramos v. Comerica Inc., 2024 WL 2104398, at *4 (C.D. Cal. Apr. 12, 2024). The analysis in the Ramos case appears to be an outlier among recent cases. One decision noted the presence of a disagreement among courts about the import of the 95 percent threshold but did not reach a holding on the issue. See Ind. Pub. Ret. Sys. v. AAC Holdings, Inc., 2023 WL 2592134, at *14 n.18 (M.D. Tenn. Feb. 24, 2023) (“[T]he Court notes that there is disagreement among the courts as to whether non-statistically significant stock price movement can evidence lack of price impact.”)
Finally, nine decisions explicitly find that statistical significance at the 95 percent threshold is not a required showing to demonstrate that a stock price movement was caused by company- or case-relevant information. One decision held that statistical significance may be established at a lower threshold, suggesting the court still considered some showing of statistical significance relevant to the court’s analysis. See Sjunde AP-Fonden v. Goldman Sachs Grp., Inc., 2024 WL 1497110, at *19 (S.D.N.Y. Apr. 5, 2024) (“There is no bright line legal or statistical rule that a result below the 95% confidence level disproves price impact—particularly at the class certification stage.”).
Notably, all nine of the decisions held that a lack of statistical significance is not alone dispositive, reasoning, for example, that “the absence of a statistically significant price adjustment does not show that the stock price was unaffected by the misrepresentation.” Del. Cnty. Emps. Ret. Sys. v. Cabot Oil & Gas Corp., 2023 WL 6300569, at *8 (S.D. Tex. Sept. 27, 2023); see also In re Cassava Scis., Inc. Sec. Litig., 2024 WL 4824243, at *14 (W.D. Tex. Nov. 15, 2024) (same); Gelt Trading Ltd. v. Co-Diagnostics, Inc., 2023 WL 5334623, at *5 (D. Utah Aug. 18, 2023) (finding “compelling” an expert report that stated “[s]tatistical significance generally proves price impact, but lack of statistical significance does not prove there was no price impact”); Spence v. Am. Airlines, Inc., 2025 WL 225127 (N.D. Tex. Jan. 10, 2025) (denying motion to exclude expert testimony that used an event study that did not apply the strict 95 percent / 5 percent statistical significance cutoff); Boston Ret. Sys. v. Alexion Pharm., Inc., 2023 WL 2932485, at *11 (D. Conn. Apr. 13, 2023) (“Although defendants may attempt to show lack of price impact by a statistically-based event study, courts have cautioned that ‘the failure of an event study to disprove the null hypothesis with respect to an event does not prove that the event had no impact on the stock price.’”); Hall v. Johnson & Johnson, 2023 WL 9017023, at *13 (D.N.J. Dec. 29, 2023) (“Here, even though the price decline was not at the traditionally ‘statistically significant’ standard, when considering the price decline in conjunction with the information published in the Release and that Defendants have not identified another explanation for the price decline, the Court concludes that Defendants have not rebutted the [fraud-on-the-market] presumption.”); Crews v. Rivian Auto., Inc., 2024 WL 3447988, at *15 (C.D. Cal. July 17, 2024) (“[A]s other courts have noted, while a statistically significant price drop after a corrective disclosure is evidence of price impact, the converse is not necessarily true.”); Sjunde, 2024 WL 1497110, at *19 (“[T]he absence of a statistically significant price drop does not disprove price impact.”); In re Apache Corp. Sec. Litig., 2024 WL 532315, at *11 (S.D. Tex. Feb. 9, 2024) (finding lack of statistical significance “a relevant fact to consider alongside Defendants’ other evidence concerning price impact” but “not dispositive of price impact”).
Conclusion
As courts continue to consider evidence on statistical significance in the context of the fraud-on-the-market presumption and loss causation in securities fraud cases, litigants and courts can expect to see parties continuing to raise disputes over the necessary threshold and impact of the statistical significance evidence.